Lates News

According to the AI news from Every News, Huatai Securities released a research report on May 7th giving a buy rating to Mindray Medical (300760.SZ). The main reasons for the rating include: 1) pressure on domestic growth, high growth in overseas markets; 2) IVD becoming the largest business, the company accelerating its transformation into a flow-based business. (Daily Economic News)